Pharmacology, Toxicology and Pharmaceutical Science
Vaccination Policy
100%
Cohort Study
60%
Statin (Protein)
46%
Non Insulin Dependent Diabetes Mellitus
44%
Randomized Controlled Trial
36%
Prevalence
33%
Influenza Vaccine
32%
Antibiotics
27%
Disease
26%
Case-Control Study
25%
Infection
22%
Asthma
22%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
21%
Pneumococcus Vaccine
20%
Urinary Tract Infection
19%
Antihypertensive Agent
18%
Antibiotic Agent
18%
Seasonal Influenza
18%
Chronic Obstructive Lung Disease
16%
Antidepressant
15%
Community Acquired Pneumonia
15%
Cardiovascular Disease
15%
CYP2D6
14%
Observational Study
13%
Adverse Event
12%
Placebo
11%
Attention Deficit Disorder
11%
Monotherapy
10%
Live Attenuated Influenza Vaccine
10%
Venlafaxine
10%
Nortriptyline
10%
Atopy
10%
Influenza Virus
10%
Pharmacotherapy
10%
Pneumococcal Infection
10%
Antilipemic Agent
9%
Beta Adrenergic Receptor Blocking Agent
9%
Human Respiratory Syncytial Virus
9%
Q Fever
9%
Respiratory Tract Infection
9%
Metformin
8%
Cardiovascular Mortality
8%
Hemoglobin A1c
8%
Streptococcus Pneumoniae
8%
Low Density Lipoprotein Cholesterol
8%
Proton Pump Inhibitor
8%
Cardiovascular Risk
8%
Fluoxetine
7%
Diabetes Mellitus
7%
Dipeptidyl Carboxypeptidase Inhibitor
7%
Medicine and Dentistry
Influenza Vaccination
61%
Influenza Vaccine
35%
Odds Ratio
31%
Cost-Effectiveness Analysis
25%
Health Care
23%
Randomized Controlled Trial
23%
Pneumococcus Vaccine
21%
Cohort Analysis
21%
General Medicine
21%
Primary Health Care
21%
Drug Therapy
20%
Infection
19%
Meta-Analysis
18%
Disease
17%
Health Care Cost
17%
Systematic Review
17%
Case-Control Study
16%
Maturity Onset Diabetes of the Young
16%
Antibiotics
14%
Community-Acquired Pneumonia
13%
Prevalence
12%
Patient with Type 2 Diabetes
11%
Kidney Graft
11%
Q Fever
10%
Quality of Life
10%
Serotype
10%
Cardiovascular Disease
10%
Urinary Tract Infection
9%
Nursing Home
9%
Seasonal Influenza
9%
General Practitioner
9%
Asthma
9%
Logistic Regression Analysis
9%
Streptococcus Pneumoniae
9%
Acute Otitis Media
9%
Patient with Diabetes
8%
Cardiovascular System
8%
Influenza A Virus (H1N1)
7%
Quality Adjusted Life Year
7%
Statin
7%
Respiratory Tract Infection
7%
Diabetes
7%
Nortriptyline
7%
Population
6%
Otitis Media
6%
Placebo
6%
Pneumococcal Infection
6%
Influenza Virus
6%
ACE Inhibitor
6%
Human Respiratory Syncytial Virus
5%
Keyphrases
Netherlands
42%
Confidence Interval
36%
Influenza Vaccination
23%
Dutch
18%
Statin Therapy
18%
Type 2 Diabetic Patients
17%
Statins
17%
Odds Ratio
14%
Inception Cohort Study
13%
Influenza
13%
Vaccination
12%
Health-related Quality of Life
11%
General Practice
11%
Patients with Diabetes
10%
Kidney Transplant Recipients
10%
Antidepressants
10%
Antihypertensive Drugs
10%
Indonesia
10%
Atopic Disease
10%
Non-adherence
9%
Primary Care
9%
General Practitioners
9%
Proton Pump Inhibitors
9%
Attention Deficit Hyperactivity Disorder
8%
Cost-effectiveness
8%
Groningen
8%
Primary Prevention
8%
During Pregnancy
8%
Risk Factors
8%
Asthma
7%
Monotherapy
7%
Statin Use
7%
Adherence Rate
7%
Prescription Database
7%
Retrospective Cohort Study
7%
Antihyperlipidemic
7%
Hospitalization
7%
Diabetes
7%
Pharmacy
7%
Cardiovascular Disease
6%
Beta-blockers
6%
Polypharmacy
6%
Vaccine Effectiveness
6%
Cardiovascular Events
6%
Drugs in Pregnancy
6%
Hazard Ratio
6%
Fluoxetine
6%
Influenza Vaccine
6%
Prospective Cohort Study
6%
Healthcare Workers
5%
